Concomitant use of glucocorticoids is unlikely to alter the efficacy of the Janus kinase inhibitor tofacitinib among patients with rheumatoid…
medwirenews.com
Baricitinib Eases Rheumatoid Arthritis Pain
The JAK inhibitor reduced pain in rheumatoid arthritis patients refractory to…
medscape.com
FDA Arthritis Panel Split on the Efficacy and Safety of Baricitinib in RA
On Monday, April 23rd the FDA convened the…
rheumnow.com
JAK-1 Inhibitor Effective for RA, but Safety Signal Troubles
The oral JAK-1 inhibitor upadacitinib is showing a strong response in…
medscape.com
